Forge Therapeutics Excites Big Guns In Antibiotic World
Emerging Company Profile: Forge Therapeutics, which licensed intellectual property from [...]
Fragment-based methods for drug screening
In the pharmaceutical industry, the “batting average” for taking a [...]
Why San Diego leaders must forge international economic partnerships
Did you know that the greatest public transportation systems in [...]
Forge Therapeutics and collaborators from Evotec and USC present new efficacy data at 2017 Keystone Symposia Conference
-Data demonstrates broad applicability for LpxC inhibitor in Acinetobacter baumannii, [...]
Preclinical antibiotic pipeline gets a pick‑me‑up
The antibiotic pipeline is running dry. An analysis by the [...]
Forge therapeutics announces participation in upcoming scientific and industry events
San Diego, California, October 24, 2017 – Forge Therapeutics, Inc. [...]
Forge Therapeutics, Evotec launch platform to discover metalloenzyme inhibitors
Less than a year after forming a strategic alliance to [...]
Forge & Evotec expand strategic alliance with launch of BLACKSMITH Platform to discover novel metalloenzyme inhibitors across broad therapeutic areas
- BLACKSMITH Platform Initially Focused on the Development of Novel [...]
Forge Therapeutics to participate in antimicrobial resistance panel at 2017 Bio Investor Forum
Forge Therapeutics to participate in antimicrobial resistance panel at 2017 [...]
UCSD – Telling the story of Forge
So you have a great idea for a research project [...]